Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-07

FDA Approved: LETROZOLE — Supplemental Application (Natco Pharma Limited)

View source ↗

Summary

FDA approves Natco Pharma Limited's supplemental application for letrozole (generic). This action updates the labeling/approval status of the generic aromatase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)

Snippet

SUPPL AP for LETROZOLE (LETROZOLE)